Corporate

Anesiva, Inc. (Nasdaq: ANSV) is a late-stage biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management.

Our lead product, Adlea, is a long-acting, local, non-opioid analgesic in late-stage clinical development for the management of post-operative pain associated with orthopedic surgery and which also has potential in the treatment of pain due to moderate-to-severe osteoarthritis.